Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-32.07	33.40	49.16
Graham Fair Price	54.80	67586.19	43660.24
PEG	-81.69	0.06	-0.34
Price/Book	4.18	1.14	1.10
Price/Cash Flow	-3.94	52.40	54.54
Prices/Earnings	-57.95	9.01	21.43
Price/Sales	14.30	7.99	6.99
Price/FCF	-3.94	52.40	54.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	12.01	0.48	0.43
Operating Margin	33.36	0.18	0.14
ROA	135.50	0.02	< 0.005
ROE	0.01	0.03	147.73
ROIC	0.02	0.02	-0.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.14	-39.23
Dividends QOQ	-0.59	-1.00	-69.09
EBIT QOQ	-0.51	0.20	-61.90
EPS QOQ	-0.63	1.44	129.63
FCF QOQ	-0.72	0.07	-90.74
Revenue QOQ	-0.15	-0.10	29.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	303.52	390.47	28.65
Days Sales Outstanding (DSO)	114.32	128.15	12.10
Inventory Turnover	0.30	0.23	-22.27
Debt/Capitalization	0.06	0.07	10.53
Quick Ratio	1.31	1.16	-11.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	81326.22	79985.85	-1.65
Cash	14794.70	17048.73	15.24
Capex	-1684.54	-1541.66	8.48
Free Cash Flow	1637.22	1746.33	6.66
Revenue	12777.54	11454.59	-10.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.40	2.11	-11.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.17	-1.30	40.15
Naive Interpretation	Member

06 - Financial Health · Bad

Rating